AstraZeneca said on Friday it has agreed to a research deal with Chinese drugmaker CSPC Pharmaceuticals worth up to $5.22 billion to focus on AI-enabled initiatives.
(Reporting by Pushkala Aripaka in Bengaluru)
Tesla CEO Elon Musk won shareholder approval on Thursday for the largest corporate pay package in history as investors endorsed...
Global hedge funds' exposure to crypto markets is increasing, and more than half are now invested in the sector, with...
This week's wobble in shares connected to artificial intelligence is a stark reminder that the U.S. stock market is ever...
Investors in pure-play quantum computing stocks are grappling to value these futuristic companies, making prices highly volatile for the latest...
AI fever has propelled global stocks to record highs, but the data centres needed to power the promised revolution are...
European banks increased their reliance on U.S. dollars last year, Europe's banking regulator said on Monday, amid growing concerns about...
© 2024 SEMG.
